Regulation of transplantation tolerance by T-cell growth factors

Central to the events of T-cell activation and acute allograft rejection is the production of T-cell growth factors, a family of cytokines with potent mitotic activities (ie, interleukin-2, -4, -7, -9, and -15) that drive the proliferation, clonal expansion, and functional maturation of alloreactive T cells. Thus, targeting T-cell growth factors or their receptor components remains one of the key aspects of transplantation immunology. However, there is compelling evidence that T-cell growth factors also regulate the acquisition of peripheral allograft tolerance through modulating apoptotic cell death of activated T cells and guiding the development of immune regulatory cells. Thus, understanding the individual and collective role of T-cell growth factors in allograft response may prove to be critically important in designing effective therapeutic strategies to promote transplantation tolerance.

[1]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[2]  T. Strom,et al.  Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance , 1999, Nature Medicine.

[3]  D. Baltimore,et al.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. , 1999, Immunity.

[4]  C. Martínez-A,et al.  An IL‐2 receptor β subdomain that controls Bcl‐XL expression and cell survival , 1999 .

[5]  T. Strom,et al.  Induction of allograft tolerance in the absence of Fas-mediated apoptosis. , 1999, Journal of immunology.

[6]  K. Wood,et al.  Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. , 1999, Journal of immunology.

[7]  J. Ihle,et al.  Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. , 1999, Immunity.

[8]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[9]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[10]  W. Fiers,et al.  Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. , 1998, Journal of immunology.

[11]  Z. Dai,et al.  Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. , 1998, Journal of immunology.

[12]  Chyung-Ru Wang,et al.  Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.

[13]  M. Zand,et al.  Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15. , 1998, Transplantation.

[14]  P. Nickerson,et al.  IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. , 1998, Journal of immunology.

[15]  K. Muegge,et al.  The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. , 1998, Journal of immunology.

[16]  C. Orosz,et al.  Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns. , 1998, Transplantation.

[17]  J. Tschopp,et al.  Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. , 1998, Immunity.

[18]  J. Sprent,et al.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.

[19]  L. Zheng,et al.  T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. , 1998, Journal of immunology.

[20]  B. Ludviksson,et al.  TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. , 1997, Journal of immunology.

[21]  R. Paus,et al.  Interleukin-15 protects from lethal apoptosis in vivo , 1997, Nature Medicine.

[22]  B. Burgering,et al.  Phosphatidylinositol 3-Kinase Links the Interleukin-2 Receptor to Protein Kinase B and p70 S6 Kinase* , 1997, The Journal of Biological Chemistry.

[23]  P. Linsley,et al.  Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. , 1997, Journal of immunology.

[24]  T. Strom,et al.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Strom,et al.  Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. , 1996, Journal of immunology.

[26]  J. Phillips,et al.  T cell regulation in adult transplantation tolerance. , 1996, Journal of immunology.

[27]  T. Waldmann,et al.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.

[28]  Kendall A. Smith,et al.  Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.

[29]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[30]  P. Nickerson,et al.  IL-2 knockout recipient mice reject islet cell allografts. , 1995, Journal of immunology.

[31]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[32]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[33]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[34]  R. Lechler,et al.  Presentation and recognition of major and minor histocompatibility antigens. , 1994, Transplant immunology.

[35]  J. Renauld,et al.  Thymic lymphomas in interleukin 9 transgenic mice. , 1994, Oncogene.

[36]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[37]  M. Lenardo lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.

[38]  E. Shevach,et al.  Interleukin 7 is a T-cell growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  N. Tanaka,et al.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. , 1996, Annual review of immunology.

[40]  J. Renauld,et al.  Interleukin-9: a T-cell growth factor with a potential oncogenic activity. , 1993, Cancer investigation.

[41]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[42]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.